HPA axis dysfunction in depression: Correlation with monoamine system abnormalities

Psychoneuroendocrinology

Volumn 22, Issue SUPPL. 1, 1997, Pages

  Mokrani, M C ^a,b   Duval, F ^b   Crocq, M A ^b   Bailey, P ^b   Macher, J P ^b  

^a Res Ctr Appl Neurosci Psychiat   (France)

^b Centre Hospitalier de Rouffach   (France)

Author keywords

Apomorphine test; Clonidine test; D fenfluramine test; Depression; DST; HPA axis; Monoamines

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; APOMORPHINE; CLONIDINE; DEXFENFLURAMINE; HYDROCORTISONE;

ADULT; ARTICLE; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; DOPAMINERGIC SYSTEM; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MONOAMINERGIC SYSTEM; NORADRENERGIC SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEROTONINERGIC SYSTEM;

ADRENERGIC ALPHA-AGONISTS; ADULT; APOMORPHINE; BIOGENIC MONOAMINES; CLONIDINE; DEPRESSIVE DISORDER; DOPAMINE AGONISTS; FEMALE; FENFLURAMINE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PSYCHIATRIC STATUS RATING SCALES; RADIOIMMUNOASSAY; SEROTONIN UPTAKE INHIBITORS;

EID: 0030880672     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(97)00012-7     Document Type: Article

References (18)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. American Psychiatric Press, Washington.
2. American Psychiatric Association (APA) Task Force on Laboratory Tests in Psychiatry (1987) The dexamethasone test suppression test: an overview of its current status in psychiatry. Am J Psychiatry 144, 1253-1262.
3. Carroll, BJ, Feinberg, M, Greden, JF, Tarika, J, Albala, AA, Hasket, RF, James, NM, Kronfol, Z, Lohr, N, Steiner, M, De Vigne, JP and Young, E (1981) A specific laboratory test for the diagnosis of melancholia: standardization, validation, and clinical utility. Arch Gen Psychiatry 38, 15-22.
4. Cleare, AJ, Bearn, J, Allain, T, McGregor, A, Wessely, S, Murray, RM and O'Keane, V (1995) Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord 34, 283-289.
5. Dinan, TG (1994) Glucocorticoids and the genesis of depressive illness: a psychobiological model. Br J Psychiatry 164, 365-371.
6. Duval, F, Mokrani, MC, Crocq, MA, Weber, N, Rosenberg, S, Castro, JO, Valdivieso, S and Macher, JP (1992) Multihormonal responses to a series of neuroendocrine tests in psychiatric patients. In: Macher JP, Crocq MA (Eds) New Prospects in Psychiatry: The Bioclinical Interface I. Elsevier, Amsterdam, pp. 192-205.
7. Duval, F, Mokrani, MC, Crocq, MA, Jautz, M, Bailey, P, Diep, TS, De Andrade, EE and Macher, JP (1995) Multihormonal responses to a series of neuroendocrine tests in psychiatry: a multivariate approach. In: Macher JP, Crocq MA, Nedelec JF (Eds) New Prospects in Psychiatry: The Bioclinical Interface. Elsevier, Paris, pp. 77-90.
8. Lal, S (1988) Apomorphine in the evaluation of dopaminergic function in man. Prog Neuropsychopharmacol Biol Psychiatry 12, 117-164.
9. Lindley, SE, Wong, DL and Schatzberg, AF (1996) Chronic corticosterone on mesocortical dopamine utilization. Biol Psychiatry 39, 629.
10. Maes, M, D'Hondt, P, Suy, E, Minner, B, Vandervorst, C and Raus, J (1991) HPA axis hormones and prolactin response to D-fenfluramine in depressed patients and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 15, 781-790.
11. Meltzer, HY, Kolakowska, T, Fang, VS, Fogg, L, Robertson, A, Lewine, R, Strahilevitz, M and Busch, D (1984) Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Arch Gen Psychiatry 41, 512-519.
12. Mokrani, MC, Duval, F, Crocq, MA, Bailey, P and Macher, JP (1995) Multihormonal responses to apomorphine in mental illness. Psychoneuroendocrinology 20, 365-375.
13. O'Keane, V and Dinan, TG (1991) Prolactin and cortisol responses to D-fenfluramine in major depression: evidence for diminished responsivity of central serotoninergic function. Am J Psychiatry 148, 1009-1015.
14. Posener, JA, Schildkraut, JJ, Williams, GH, Gleason, RE, Salomon, MS, Mecheri, G and Schatzberg, AF (1994) Acute and delayed effects of corticotropin releasing hormone on dopamine activity in man. Biol Psychiatry 36, 616-621.
15. Rubin, AL, Price, LH, Charney, S and Heninger, GR (1985) Noradrenergic function and the cortisol response to dexamethasone in depression. Psychiatry Res 15, 5-15.
16. Siever, LJ, Uhde, TW, Silberman, EK, Jimerson, DC, Aloi, JA, Post, RM and Murphy, DL (1982) The growth hormone response to clonidine as a probe of noradrenergic responsiveness in affective disorder patients and controls. Psychiatry Res 6, 171-183.
17. Siever, LJ, Murphy, DL, Slater, S, de la Vega, E and Lipper, S (1984) Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotoninergic responsivity in depression. Life Sci 34, 1029-1039.
18. Tuomisto, J and Männistö, P (1985) Neurotransmitter regulation of anterior pituitary hormones. Pharmacol Rev 37, 249-332.